ARTICLE | Distillery Therapeutics
Trastuzumab-RNA polymerase inhibitor conjugate for breast cancer with low HER2 expression
February 27, 2021 1:08 AM UTC
DISEASE CATEGORY: Cancer
INDICATION: Breast cancer...
BCIQ Company Profiles
DISEASE CATEGORY: Cancer
INDICATION: Breast cancer...
BCIQ Company Profiles
BCIQ Company Profiles